01 Industry overview
The medical manufacturing industry at a glance
Medical manufacturing is expanding through outsourced production: the global medical device contract-manufacturing market reached $84.6 billion in 2025 and is forecast to grow at a 12.6% CAGR through 2033.
- $84.6B[10]
- Contract manufacturing market, 2025
- 12.6%[10]
- Contract manufacturing CAGR, 2026–2033
- 36,000+[11]
- European medtech companies, 2026
- 90%[11]
- European firms that are SMEs, 2026
- Market size
- The global medical device market generated $508.3 billion in revenue in 2024, the latest broad global estimate identified. Europe’s medical technology market excluding in-vitro diagnostics generated €170 billion in 2024.[4][11]
- Forecast & CAGR
- The global medical device market is projected to reach $717.4 billion by 2030, implying a 5.9% CAGR from 2024. The narrower medical device contract-manufacturing market is forecast to grow from $84.6 billion in 2025 to $214.3 billion in 2033, a 12.6% CAGR.[4][10]
- Market share & regions
- The United States accounted for 46.4% of the global medical device market in 2024, followed by Europe at 26.4%, China at 6.5% and Japan at 4.7%. A separate regional mapping estimates North America at 38%, Europe at 27% and Asia-Pacific at 24% of the 2024 global market.[12][13]
- Segmentation
- Medical manufacturing spans devices and diagnostics, including wound dressings, syringes, implants, imaging systems, hearing aids, pacemakers, glucose monitors and in-vitro diagnostic tests. More than two million medical technologies are in use across Europe, illustrating the sector’s highly fragmented product base.[11]
- Key players & concentration
- The United States accounted for about 40% of global medical-device production in 2024, while Germany accounted for 15% and China for 10%, indicating concentration among a small number of major manufacturing hubs. Europe had more than 36,000 companies in 2026, with around 90% classified as SMEs.[13][11]
- Pricing
- The U.S. producer price index for surgical and medical instrument manufacturing was 161.757 in March 2026, compared with 159.452 in November 2025. FDA FY2027 fees include a $13,785 annual establishment-registration fee and a standard $28,653 510(k) submission fee.[7][6]
- Trends, drivers & challenges
- Growth is being supported by aging populations, non-communicable diseases, healthcare spending, digital-health adoption and investment in domestic production capacity. Key constraints include supply-chain resilience, tariffs, rising regulatory costs and procurement pressure, particularly for smaller manufacturers.[4][11]
- Consumer behavior & competition
- Competition is increasingly focused on high-growth technologies such as robotics, structural heart devices, pulse-field ablation and diabetes-care products. MedTech Europe reported more than 15,900 European patent applications in 2025, compared with 15,700 in 2024, indicating sustained innovation competition.[14][11]
- M&A
- Global medtech M&A spending reached $38.8 billion in 2024, while the average deal size rose to $497 million, 11% higher than in 2024 and 72% above the average of the prior decade. In 2026, KKR agreed to acquire Integer Holdings for approximately $5.7 billion, highlighting continued consolidation among outsourced medical-device manufacturers.[14][15]
- Regulation
- U.S. manufacturers face FDA registration and product-submission fees under MDUFA; FY2027 fees run from $8,596 for a 513(g) request to $636,732 for a standard PMA, PDP, PMR or BLA application. FDA’s proposed MDUFA VI framework covers FY2028–FY2032 and would reduce domestic registration and marketing-submission fees.[6]
- Latest news
- Recent industry activity includes KKR’s 2026 take-private acquisition of Integer Holdings for an enterprise value of approximately $5.8 billion and Teleflex’s $1.5 billion medical-device OEM carve-out. These transactions reinforce private-equity interest in scaled contract-development and manufacturing platforms.[15][16]
02 Ranking
Top 10 Companies in the Medical Manufacturing Industry
The leading companies in the medical manufacturing industry, ranked on market impact, performance, momentum, innovation and brand popularity.
Updated November 21, 2026 · Next review December 21, 2026
Medtronic stands out for cardiovascular, neuroscience, surgical, and diabetes device manufacturing because it reported $36.4 billion in worldwide FY2026 revenue, while Siemens Healthineers focuses on imaging, diagnostics, cancer care and patient monitoring since it generated about €23.4 billion in FY2025 revenue.
Ranked by Overall score · How we score ↓
Editor's top 3 picks
Where to start, by need.
#1 Overall · Leader in cardiovascular devices
Medtronic
IE
Ranked #1 · 9.1 · Cardiovascular devices
Why we picked it: Its cardiovascular, neuroscience, surgical, and diabetes device portfolio is backed by an 17.8% operating margin in worldwide FY2026.
Leader in imaging and diagnostics
Siemens Healthineers
DE
Ranked #2 · 9.0 · Imaging and diagnostics
Why we picked it: Imaging, diagnostics, cancer care, and patient monitoring are supported by about €23.4 billion in FY2025 revenue and a 16.5% operating margin.
Leader in surgery and vision
Johnson & Johnson
US
Ranked #3 · 9.0 · Surgery and vision
Why we picked it: MedTech devices, surgery, and vision products are reflected in $33.8 billion MedTech segment sales in 2025.
Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.
Full ranking
| # | Company | Overall ↓ | Impact | Performance | Momentum | Innovation | Company snapshot |
|---|---|---|---|---|---|---|---|
| 1 | Medtronic Cardiovascular devices · IE | 9.1 | 9.3 | 8.7 | 9.1 | 8.4 | |
Company snapshot · Medtronic · Data as of November 21, 2026 Medtronic reported $36.4 billion in worldwide FY2026 revenue.[17]
| |||||||
| 2 | Siemens Healthineers Imaging and diagnostics · DE | 9.0 | 9.1 | 8.3 | 8.7 | 9.4 | |
Company snapshot · Siemens Healthineers · Data as of November 21, 2026 Siemens Healthineers generated about €23.4 billion in FY2025 revenue.[18]
| |||||||
| 3 | Johnson & Johnson Surgery and vision · US | 9.0 | 9.9 | 8.2 | 8.7 | 9.6 | |
Company snapshot · Johnson & Johnson · Data as of November 21, 2026 Its MedTech segment generated $33.8 billion in 2025 sales.[19]
| |||||||
| 4 | Boston Scientific Interventional procedures · US | 9.0 | 7.9 | 9.9 | 9.9 | 9.3 | |
Company snapshot · Boston Scientific · Data as of November 21, 2026 Boston Scientific develops and manufactures medical technologies for interventional specialties.[20]
| |||||||
| 5 | Edwards Lifesciences Cardiovascular devices · US | 8.8 | 7.9 | 9.2 | 9.2 | 9.9 | |
Company snapshot · Edwards Lifesciences · Data as of November 21, 2026 Edwards reported full-year 2025 sales growth of 11.5% and focuses on structural heart technologies.[21]
| |||||||
| 6 | Stryker Orthopaedics, surgical and neurovascular technologies · US | 8.7 | 8.3 | 9.1 | 9.2 | 8.5 | |
Company snapshot · Stryker · Data as of November 21, 2026 Stryker says its products impact more than 150 million patients annually.[22]
| |||||||
| 7 | Danaher Diagnostics, biotechnology and life-science instruments · US | 8.3 | 9.1 | 8.3 | 7.9 | 8.5 | |
Company snapshot · Danaher · Data as of November 21, 2026 Danaher's 2025 diagnostics revenue was $9.94 billion.[23]
| |||||||
| 8 | Smith+Nephew Orthopaedics, sports medicine and wound care · GB | 8.2 | 7.2 | 8.1 | 9.0 | 9.4 | |
Company snapshot · Smith+Nephew · Data as of November 21, 2026 Smith+Nephew reported $6.164 billion group revenue for 2025.[24]
| |||||||
| 9 | BD Injection, medication delivery and diagnostic systems · US | 8.2 | 8.6 | 7.8 | 8.0 | 8.0 | |
Company snapshot · BD · Data as of November 21, 2026 BD reported $21.8 billion in FY2025 revenue across three medical-technology segments.[25]
| |||||||
| 10 | Zimmer Biomet Orthopaedic implants and surgical technologies · US | 8.2 | 8.0 | 8.2 | 8.4 | 8.0 | |
Company snapshot · Zimmer Biomet · Data as of November 21, 2026 Zimmer Biomet employed approximately 17,000 people worldwide at December 31, 2025.[26]
| |||||||
How we score
- Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
- Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
- Momentum (20%): growth trajectory and future potential.
- Innovation (15%): R&D intensity and how technologically advanced the company is.
Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.
Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.
Cadence Recalculated when new figures are published; next review December 21, 2026.
Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.
Cite this ranking
APA
Samuel Norberg. (2026, November 21). Top 10 companies in the medical manufacturing industry. In Medical Manufacturing Industry Statistics. Gitnux. https://gitnux.org/medical-manufacturing-industry-statistics/#top-companies
Revenue of the largest medical manufacturing companies
Johnson & Johnson leads with $94.2B in annual revenue (group level, converted to USD).
03 Trends & forecasts
Top 10 Medical Manufacturing Industry Trends & Forecasts 2027
What is changing in the medical manufacturing industry, with the evidence behind each trend and a forecast for 2027.
Forecasts were generated by an AI model from the cited evidence. They are estimates, not guarantees.
01Outsourcing accelerates toward $100 billion
High confidenceThe global medical-device contract-manufacturing market was valued at $84.6 billion in 2025 and is estimated at $93.5 billion in 2026, with a projected 12.6% CAGR through 2033. Demand is being supported by OEM outsourcing, complex devices and customized production.[10]
Forecast 2027: The market should exceed $100 billion in 2027, assuming the reported growth path continues. Outsourced development, assembly, sterilization and packaging will take a larger share of OEM value chains.
02Aging populations expand device demand
High confidenceThe United Nations projects that the global population aged 60 or over will rise from 1.2 billion in 2024 to 1.6 billion in 2034, a 33.3% increase. Aging supports demand for implants, cardiovascular devices, mobility products, hearing aids and home-care equipment.[27]
Forecast 2027: In 2027, manufacturers should see sustained volume growth in orthopedic, cardiovascular, diagnostic and assistive technologies. Product designs will increasingly emphasize aging in place, ease of use and lower-care settings.
03Chronic disease sustains recurring demand
High confidenceThe World Health Organization reports that noncommunicable diseases caused at least 43 million deaths in 2021, equal to 75% of non-pandemic-related deaths globally. Cardiovascular disease, cancer, chronic respiratory disease and diabetes continue to support demand for monitoring, diagnostics and therapeutic devices.[28]
Forecast 2027: Through 2027, diabetes-care, cardiovascular, respiratory and oncology-related products should remain among the strongest demand pools. Manufacturers will prioritize lower-cost, portable and remotely connected products for long-term disease management.
04European medtech growth remains subdued
High confidenceMedTech Europe reported that European medical-device market growth slowed to 1.8% in 2025, compared with a ten-year average of 5.6%. The association also reported more than 36,000 European medical-technology companies, with around 90% classified as SMEs.[11]
Forecast 2027: European manufacturers are likely to experience low-single-digit demand growth in 2027, with stronger performance in diagnostics, digital tools and high-value devices. Smaller companies will remain important but face greater pressure from compliance costs and procurement constraints.
05Medical-device prices continue rising
Medium confidenceThe U.S. producer price index for surgical and medical instrument manufacturing increased from 159.452 in November 2025 to 161.757 in March 2026. The increase indicates continued producer-price pressure across the instrument-manufacturing base.[7]
Forecast 2027: Prices should remain elevated in 2027, although the rate of increase may moderate if materials and freight markets stabilize. Manufacturers will seek productivity gains, design-for-manufacture savings and selective pass-through of higher costs.
06Patent activity strengthens innovation competition
High confidenceMore than 15,900 medical-technology patent applications were filed with the European Patent Office in 2025, up 1.2% from the previous year. Medical technology was the fourth-largest technical field by application volume and accounted for 7.9% of all applications.[11]
Forecast 2027: Patent filings should remain near record levels in 2027, particularly in minimally invasive surgery, cardiovascular care, connected monitoring and diagnostic automation. Competitive advantage will depend increasingly on protected software, materials and manufacturing processes as well as hardware.
07Connected and digital devices gain share
Medium confidenceMedical technology products typically have an 18–24 month lifecycle, while the sector’s estimated global R&D investment rate is approximately 6.5%–7% of sales. These characteristics favor faster product iteration and the integration of sensors, software, connectivity and analytics.[11]
Forecast 2027: By 2027, connected monitoring and software-enabled devices should represent a larger portion of new product launches. Manufacturers will invest more in embedded electronics, cybersecurity, data interoperability and recurring software-support capabilities.
08Asia-Pacific remains the outsourcing hub
High confidenceAsia-Pacific accounted for 41.5% of global medical-device contract-manufacturing revenue in 2025, according to Grand View Research. The region benefits from established production capacity, cost advantages and growing healthcare infrastructure investment.[10]
Forecast 2027: Asia-Pacific should retain the largest regional share in 2027, but production footprints will become more diversified. OEMs are likely to combine Asian scale with North American or European capacity for critical, regulated or politically sensitive products.
09Supply chains diversify beyond single hubs
Medium confidenceThe medical-device contract-manufacturing market is expanding alongside reported industry concerns about supply-chain resilience, tariffs and offshore dependence. Regional concentration remains significant, with major manufacturing activity centered in the United States, Germany, China and Asia-Pacific.[10][11]
Forecast 2027: In 2027, dual sourcing, regional final assembly and strategic inventories should become more common. Manufacturers will accept some additional unit cost in exchange for shorter lead times, better traceability and lower disruption risk.
10Regulatory fees raise small-firm barriers
High confidenceFor FDA fiscal year 2027, the annual establishment-registration fee is $13,785, the standard 510(k) fee is $28,653 and the standard PMA, PDP, PMR or BLA fee is $636,732. Europe has more than 36,000 medtech companies and about 90% are SMEs, making regulatory cost especially material for the sector’s company base.[6][11]
Forecast 2027: Regulatory cost and documentation requirements will continue to favor scale in 2027. Smaller manufacturers will increasingly rely on specialized consultants, contract manufacturers and regulatory partnerships to spread compliance overhead.
04 Statistics
Market Intelligence
The market set shows two global 2024 baselines ($623.0 billion and $508.3 billion) and a 2030 projection of $729.8 billion. It also tracks FDA establishment counts in FY2025.
Market size, volume and shipments in the medical manufacturing industry
- $623.0 billion was the global 2024 medical-device market, covering medical equipment and consumables in Frost & Sullivan’s definition.[1]
- $100.444 billion in 2024 shipments for U.S. medical equipment and supplies manufacturing, defined as NAICS 3391 shipments reported by the Annual Integrated Economic Survey.[2]
- $32.609 billion was Japan’s 2024 medical-device market size, calculated as local production plus imports minus exports.[3]
Forecast growth and shipments in the medical manufacturing industry
Company counts and size structure in the medical manufacturing industry
- 15,850 foreign medical-device establishments were registered with FDA in FY2025.[6]
- 29,178 medical-device establishments registered with FDA in FY2025, including establishments involved in producing or distributing devices for the U.S. market.[6]
- 13,328 domestic medical-device establishments were registered with FDA in FY2025.[6]
05 Statistics
People & Workforce
U.S. medical equipment and supplies manufacturing shows wage data for October 2026 under NAICS 3391, including $38.26 per hour for all employees. It also lists 2024 injury and illness indicators per 100 full-time workers.
Wages and labour costs in the medical manufacturing industry
- $38.26 per hour was the average hourly wage for all employees in U.S. medical equipment and supplies manufacturing in October 2026, under NAICS 3391.[7]
- $1,503.62 per week was the average weekly wage for all employees in U.S. medical equipment and supplies manufacturing in October 2026, under NAICS 3391.[7]
- $28.88 per hour was the average hourly wage for production and nonsupervisory employees in U.S. medical equipment and supplies manufacturing in October 2026, under NAICS 3391.[7]
Workplace safety in the medical manufacturing industry
- 0.8 cases involving days away from work, job restriction or transfer occurred per 100 full-time workers in U.S. medical equipment and supplies manufacturing in 2024; classification used was 2017 NAICS 3391.[7]
- 1.5 recordable occupational injury and illness cases occurred per 100 full-time workers in U.S. medical equipment and supplies manufacturing in 2024; classification used was 2017 NAICS 3391.[7]
- 4,800 nonfatal occupational injury and illness cases were reported in U.S. medical equipment and supplies manufacturing in 2024; counts are in thousands and classification used was 2017 NAICS 3391.[7]
- 4 fatal occupational injuries occurred in U.S. medical equipment and supplies manufacturing in 2024; classification used was 2017 NAICS 3391.[7]
06 Statistics
Regulation & Risk
FDA registration counts in FY2025 total 29,178 medical-device establishments, split across 13,328 domestic and 15,850 foreign. FY2024 recall starts span 108 Class I through 741 Class II.
Regulations and compliance for medical manufacturing
- 15,850 foreign medical-device establishments were registered with FDA in FY 2025 under FD&C Act section 510.[6]
- 13,328 domestic medical-device establishments were registered with FDA in FY 2025 under FD&C Act section 510.[6]
- 29,178 medical-device establishments were registered with FDA in FY 2025, including 13,328 domestic and 15,850 foreign establishments under FD&C Act section 510.[6]
Enforcement and penalties in the medical manufacturing industry
- 16 Class III medical-device recalls were initiated in FY 2024, representing the lowest-risk recall class.[8]
- 741 Class II medical-device recalls were initiated in FY 2024, representing the moderate-risk recall class.[8]
- 108 Class I medical-device recalls were initiated in FY 2024, the highest-risk recall class in FDA’s classification system.[8]
Recalls and safety notices for medical manufacturing
- 1,017 medical-device recalls were recorded in FDA data during FY 2024, exceeding the combined totals for biologics and drugs.[8]
- 3,934 medical-device recalls were initiated during FY 2020–2024, according to GAO’s analysis of FDA recall data.[8]
- 62% of 3,934 medical-device recalls initiated during FY 2020–2024 were still ongoing when GAO reviewed the data.[9]
Key questions about the medical manufacturing industry
What is the current scale of the global medical device market?
How fast is medical-device revenue growing?
Which companies lead the medical manufacturing industry?
What technology shifts are showing up in medical manufacturing?
How is the market structured around manufacturing capacity?
What regulatory cost pressure matters for manufacturers in the U.S.?
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Samuel Norberg. (2026, November 21). Medical Manufacturing Industry Statistics. Gitnux. https://gitnux.org/medical-manufacturing-industry-statistics
Samuel Norberg. "Medical Manufacturing Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/medical-manufacturing-industry-statistics.
Samuel Norberg. 2026. "Medical Manufacturing Industry Statistics." Gitnux. https://gitnux.org/medical-manufacturing-industry-statistics.
Sources & references
28 sources cited across this report
www1.hkexnews.hk
fred.stlouisfed.org
trade.gov
- ustlfsci.hkust.edu.hk
- sebi.gov.in
fda.gov
bls.gov
gao.gov
files.gao.gov
grandviewresearch.com
medtecheurope.org
health.ec.europa.eu
- abiis.org.br
ey.com
capstonepartners.com
- gsmedtech.com
news.medtronic.com
siemens-healthineers.com
investor.jnj.com
bostonscientific.com
ir.edwards.com
stryker.com
investors.danaher.com
smith-nephew.com
investors.bd.com
investor.zimmerbiomet.com
documents.un.org
who.int